Novo Nordisk 's ( NVO +2.93%) shareholders must be happy to see 2025 finally come to a close. It was not a good year for the ...

Drugmaker Novo Nordisk (NVO) will offer a reduced 2025 yearly bonus to its employees in Denmark due to the company’s lowered forecast, Bloomberg reported on Friday, citing a company spokesperson. The ...

(Bloomberg) -- A rebound in Denmark’s pharmaceutical industry, dominated by Novo Nordisk A/S, powered the economy to its fastest quarterly expansion in almost four years. Gross domestic product rose 2 ...

Weaker prospects for pharmaceutical giant Novo Nordisk A/S (NYSE:NVS) have prompted Denmark's economic ministry to cut its 2025 GDP forecast, now expecting just 1.4% growth, down 1.5 percentage points ...

Novo Nordisk should remain one of the leaders in the fast-growing weight loss market, and the company's shares are trading at ...

LONDON/COPENHAGEN, Oct 15 (Reuters) - Romel Amineh is one of a fast-growing group of Novo Nordisk workers in Denmark laid off as the drugmaker battles to cut costs and revive its fortunes in a ...

FRANKFURT, Germany — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the ...

COPENHAGEN, Dec 4 (Reuters) - Denmark on Thursday sharply raised its economic growth forecast for 2025, due in part to the pharmaceuticals industry, which is performing well, its economy minister said ...

Bagsværd, Denmark, 31 December 2025 - Today, the Supreme People’s Court in China made a positive decision concerning the ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

Novo Nordisk has won the race to secure approval from the FDA for the first weight-loss drug to be administered orally ...